The 2 analysts offering 12-month price forecasts for Biocept Inc have a median target of 2.03, with a high estimate of 2.06 and a low estimate of 2.00. The median estimate represents a +125.93% increase from the last price of 0.90.
The current consensus among 2 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.05
Reporting Date Nov 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.